Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015. - Test2 - elhamkhani - TriplyDB

Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015.

Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015.

http://www.wikidata.org/entity/Q37535900

about

Insights from clinical research completed during the west Africa Ebola virus disease epidemic.Enhanced case management can be delivered for patients with EVD in Africa: Experience from a UK military Ebola treatment centre in Sierra Leone.

P2860

Q30234590-BDC83FE9-92E2-49CE-9466-AA48B9030020 Q47297019-A227DD58-61DE-434D-8151-55F6DCF48367

P2860

Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015.

http://www.wikidata.org/entity/Q37535900

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Electrolyte and Metabolic Dist ...... Clinical Trial, Guinea, 2015.

@en

Electrolyte and Metabolic Dist ...... Clinical Trial, Guinea, 2015.

@nl

type

label

Electrolyte and Metabolic Dist ...... Clinical Trial, Guinea, 2015.

@en

Electrolyte and Metabolic Dist ...... Clinical Trial, Guinea, 2015.

@nl

prefLabel

Electrolyte and Metabolic Dist ...... Clinical Trial, Guinea, 2015.

@en

Electrolyte and Metabolic Dist ...... Clinical Trial, Guinea, 2015.

@nl

P1433

Q37535900-011CA674-908D-468B-8433-8A7481E5FD51

P1476

Q37535900-27E56AC9-2C10-438F-ABD2-1CABC11D9D40

P2093

Q37535900-01B42550-4D23-4560-BAAA-A8DF785E705F

Q37535900-1E7D4E78-36E8-4439-9121-0FAFCFC9BC8D

Q37535900-1F5898A3-EE16-4057-8163-FA56061F238D

Q37535900-2239E055-8C32-4FD1-9DBB-809B04970C03

Q37535900-583517C9-33BB-45DC-9EE3-ADBE978AAB77

Q37535900-7EBA965E-201D-488C-80AD-30137903DFE7

Q37535900-8D0C71E5-F6CC-4250-BA72-9C90F6B8D007

Q37535900-A3F0BA2E-EABE-4531-899C-7ADA1BC149C6

Q37535900-A7BB0C38-4764-47AB-A464-B167A18A8745

Q37535900-C41062C3-5B22-43DE-9D02-75ED5AA88344

P2860

Q37535900-028B97B0-F60E-499C-A121-52FDA6B7D392

Q37535900-1BE7AF2A-71B7-44F8-A972-BB6C3B3835A2

Q37535900-3572E076-E507-449E-ADE0-0514AB8FA4AA

Q37535900-3CCC4955-E84D-4E96-BF9E-704FFC8E38EB

Q37535900-41B486BD-0139-4ABE-8E8B-BCAE2961C69D

Q37535900-4625E18F-1942-4839-9E59-71A8D299788D

Q37535900-4F28AD15-9EAC-4B71-A120-649B9B1304BD

Q37535900-55E24A5A-1681-456D-A4B4-74B555787461

Q37535900-55F8028F-C96B-423E-8862-C7DB7B92937F

Q37535900-644CA8D2-E6F0-4D39-8915-D0D34BE28D74

P31

Q37535900-02DA656A-E598-4C6C-9080-9793F36C246F

P356

Q37535900-25C3219E-3B8E-43D3-9B20-E98AB0585D42

P433

Q37535900-B4601AC9-2A29-4635-89CC-523E8EB49377

P478

Q37535900-746EF00A-5DB5-4586-9BFF-90A70854D4DC

P50

Q37535900-0607277C-915C-4A27-B777-499AA45E9480

Q37535900-AB42A5BF-EB41-4EAC-9C2D-DD11EBE12111

Q37535900-CFBE4032-B3BA-4F72-A103-59D316C6B496

Q37535900-DFA03953-7077-44F6-B441-DA34C93A4074

P577

Q37535900-3D8D3789-2391-4FB3-8A75-012B5598DA6F

P698

Q37535900-1D5CE4A4-5DBF-4E63-B2F4-460E82981DC9

P921

Q37535900-1FBFCD2E-78A8-4A07-80EE-071CA1845886

Q37535900-BA2A5423-6CD8-4799-B612-DC3AACC6C5C9

P932

Q37535900-6F6677F9-489B-4DF6-8D33-5F2D0C0EC347

P356

P1433

Emerging Infectious Diseases

P1476

Electrolyte and Metabolic Dist ...... Clinical Trial, Guinea, 2015.

@en

P2093

Alexandre Delamou

http://www.w3.org/2001/XMLSchema#string

Bienvenu Salim Camara

http://www.w3.org/2001/XMLSchema#string

Ebola-Tx Consortium

http://www.w3.org/2001/XMLSchema#string

Elhadj Ibrahima Bah

http://www.w3.org/2001/XMLSchema#string

Hilde De Clerck

http://www.w3.org/2001/XMLSchema#string

Johan van Griensven

http://www.w3.org/2001/XMLSchema#string

Jozefien Buyze

http://www.w3.org/2001/XMLSchema#string

Kadio Jean-Jacques Olivier

http://www.w3.org/2001/XMLSchema#string

Maaike De Crop

http://www.w3.org/2001/XMLSchema#string

Michel Van Herp

http://www.w3.org/2001/XMLSchema#string

P2860

Parenteral calcium for intensive care unit patients

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial

Prognosis Research Strategy (PROGRESS) 3: prognostic model research

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.

Clinical illness and outcomes in patients with Ebola in Sierra Leone.

Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study.

A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea.

Clinical Management of Ebola Virus Disease in the United States and Europe

P31

scholarly article

P356

10.3201/EID2212.161136

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Malcolm G. Semple

Anja De Weggheleire

Helena Nordenstedt

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27869610

http://www.w3.org/2001/XMLSchema#string

P921

2014 Ebola virus epidemic in Guinea

P932

5189166

http://www.w3.org/2001/XMLSchema#string